Agape ATP Corp ATPC
Medical/Nursing Services · data as of November 13, 2026
Agape ATP Corp (ATPC) is a healthcare company listed in the US with a market value of about $1M. In the twelve months to June 30, 2026 it had revenue of $1M and net income of -$1M, a net margin of -100.2%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -15% a year, a 5-year average ROIC of -55%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 69% below the current price.
About Agape ATP
Agape ATP is listed in the US and classified in medical/nursing services. Revenue went from $487005 in 2018 to $2M in 2025, growth of about 17.7% a year. It was profitable in 1 of the last 9 years in our data. Its share count rose by 812% over three years (dilution for shareholders).
Score: 0.8 / 5
Checks passed
- Revenue growth above 10% last year
- Profit margin improving
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 9 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $1M | $1M | $2M | $1M | $3M | $1M | $487005 | — |
| Net income | -$1M | -$2M | -$2M | -$2M | -$2M | -$3M | $354766 | -$716127 | -$130274 | -$75362 |
| Free cash flow | — | — | — | — | — | -$849801 | -$562685 | — | — | — |
| EPS (diluted) | $-1.15 | $-2.85 | $-31.74 | $-27.50 | $-20.00 | $-10.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net margin | -100.2% | -149.6% | -186.8% | -146.9% | -90.9% | -248.2% | 10.3% | -55.5% | -26.8% | — |
| ROIC | — | -11.4% | -94.2% | -35.9% | -94.2% | -41.3% | -1.7% | -7.3% | -3.6% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Agape ATP stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 69% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Agape ATP pay a dividend?
Not currently.
Is Agape ATP a good stock to buy?
We do not give buy or sell advice. Agape ATP scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.